Skip to main content

Clinical Aspects of Prostate Cancer

  • Chapter
Atlas of the Prostate
  • 247 Accesses

Abstract

An understanding of the gross anatomic relationship of the prostate to other structures within the male pelvis is of great medical importance. Because benign prostatic hyperplasia and adenocarcinoma of the prostate are common conditions of aging men, a clear understanding of the anatomic relationships among the prostate, seminal vesicles, and bladder is important for developing the concepts necessary to understand the clinical aspects and management of early stage prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Laurenson RD: An Introduction to Clinical Anatomy by Dissection of the Human 17. Body. Philadelphia: WB Saunders; 1968.

    Google Scholar 

  2. Greene DR, Shabsigh R, Scardino PT: Urologic ultrasonography. In Campbell’s 18. Urology, edn 6. Edited by Walsh PC, Retik AB, Stamey TA, Vaughan ED, Jr. Philadelphia: WB Saunders; 1992: 344–393.

    Google Scholar 

  3. Stamey TA, McNeal JE: Adenocarcinoma of the prostate. In Campbell’s Urology, 19. edn 6. Edited by Walsh PC, Retik AB, StameyTA, Vaughan ED, Jr. Philadelphia: WB Saunders; 1992: 1181.

    Google Scholar 

  4. Resnick MI, Older RA: Diagnosis of Genitourinary Disease, edn 2. New York: Thieme; 1997.

    Google Scholar 

  5. Tanagho EA: Physical examination of the genitourinary tract. Smith’s General Urology, edn 12. Edited by Tanagho EA, McAninch JW. Norwalk: Appleton and 21. Lange; 1988: 40–47.

    Google Scholar 

  6. Carter HB, Partin AW: Diagnosis and staging of prostate cancer. In Campbell’s 22. Urology, edn 7. Edited by Walsh PC, Retik AB, Wein Ai, Vaughan ED, Jr. Philadelphia: WB Saunders; 1998: 2522.

    Google Scholar 

  7. Beduschi MC, Oesterling JE: Prostate-specific antigen density. Urol Clin North 23. Am 1997, 24: 323–332.

    CAS  Google Scholar 

  8. Carter HB, Pearson JD, Metter JE, et al.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992, 267: 2215–2220.

    Article  PubMed  CAS  Google Scholar 

  9. Oesterling JE, Jacobson SJ, Chute CG, et al.: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. DAMA 1993, 270:860–864.

    CAS  Google Scholar 

  10. Morgan TO, Jacobson SJ, McCarthy WF, et al.: Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med 1996, 335: 304–310.

    Article  PubMed  CAS  Google Scholar 

  11. Partin AW: The clinical utility of prostate-specific antigen: critical issues for 1997. Advances in Prostate Cancer 1997: 2–4.

    Google Scholar 

  12. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 1995, 45: 2–12.

    Article  PubMed  CAS  Google Scholar 

  13. Terris MK, McNeal JE, StameyTA, et al.: Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992, 148: 829–832.

    PubMed  CAS  Google Scholar 

  14. Kirby RS, Christmas TJ, Brawer MJ: Prostate Cancer. Wilmington, DE: Zeneca Press; 1996: 82.

    Google Scholar 

  15. Partin AW: Issues in the Diagnosis and Prognosis of Prostate Cancer: A Slide Lecture Series. Oklahoma City: Cytodiagnostics (UROCOR ); 1995.

    Google Scholar 

  16. Prostate Cancer: Management of Advanced Disease. Wilmington, DE: ICI Pharmaceutical; 1995.

    Google Scholar 

  17. Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975, 2: 105–124.

    PubMed  CAS  Google Scholar 

  18. Gishman JR, de Vere White RW: Prostate cancer: screening, diagnosis, and staging. In Clinical Urology. Edited by Krane RJ, Siroky MB, Fitzpatrick JM. Philadelphia: JB Lippincott; 1994: 947–948.

    Google Scholar 

  19. Stamey TA, McNeal JE, Yemoto CM, et al.: Biological determinants of cancer progression in men with prostate cancer. DAMA 1999, 281:1395–1400.

    CAS  Google Scholar 

  20. Pan CC, Potter SR, Partin AW, et al.: The prognostic significance of tertiary Gleason patterns of higher grade in the radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 2000, 24:563–569.

    Article  PubMed  CAS  Google Scholar 

  21. Gleason D: Urologic Pathology: The Prostate. Edited by Tannenbaum M. Philadelphia: Lea & Febiger; 1997: 171–198.

    Google Scholar 

  22. Partin AW, Kaftan MW, Subong ENP, et al.: Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277:1445–1451.

    Article  Google Scholar 

  23. Using the Updated Partin Nomogram. Deerfield, IL: TAP Pharmaceuticals; 1997.

    Google Scholar 

  24. Graefen M, Karakiewicz PI, Cagiannos I, et al.: Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol2002, 20: 951–956.

    Article  PubMed  Google Scholar 

  25. D’Amico AV, Whittington R, Malkowicz SB, et al.: Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999, 17: 168–172.

    PubMed  Google Scholar 

  26. Bostwick DG: Issues in the Diagnosis and Prognosis of Prostate Cancer. Oklahoma City: Cytodiagnostics (UROCOR) Speaker Support Program; 1995.

    Google Scholar 

  27. Gpoalkrishnan RV, Kang DC, Fisher PB: Molecular markers and determinants of prostate cancer metastasis. J Cell Physiol 2001, 189: 245–256.

    Article  Google Scholar 

  28. Humphrey PA, Keetch DW, Smith DS, et al.: Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate-specific antigen based screening. J Urol 1996, 155:816–820.

    Article  PubMed  CAS  Google Scholar 

  29. Epstein JI, Walsh PC, Carmichael M, Brendler CB: Pathologic and clinical findings to predict tumor extent of non-palpable (stage Ti c) prostate cancer. JAMA 1994, 271: 368–374.

    Article  PubMed  CAS  Google Scholar 

  30. von Eschenbach A, Ho R, Murphy GP, et al.: American Cancer Society Guidelines for the early detection of prostate cancer. Cancer 1997, 80: 1805–1807.

    Article  Google Scholar 

  31. National Center for Health Statistics, 1998: http//www.cdc.gov/nchs/default.htm. Accessed Sept. 16, 2002.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Current Medicine, Inc.

About this chapter

Cite this chapter

Ernstoff, M.S. (2003). Clinical Aspects of Prostate Cancer. In: Bruskewitz, R.C. (eds) Atlas of the Prostate. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6505-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6505-5_8

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4615-6507-9

  • Online ISBN: 978-1-4615-6505-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics